Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Trastuzumab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Breast Neoplasms 20 Stomach Neoplasms 6 Esophageal Neoplasms 5 Neoplasms 4 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Solid Tumors 1 Resectable HER2-positive Breast Cancer 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Gastric Cancer 1 HER2-positive Early Breast Cancer 1 Gastroesophageal Adenocarcinoma 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1

Interventions

Cyclophosphamide 14 Rituximab 12 fludarabine 11 obinutuzumab 8 fludarabine phosphate 6 tocilizumab 5 ibrutinib 5 Prednisone 5 Lenalidomide 5 glofitamab 4 Specimen Handling 4 Doxorubicin 4 Biopsy 4 polatuzumab vedotin 3 pirtobrutinib 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 venetoclax 2 acalabrutinib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Oxaliplatin 2 Nuclear Medicine Department, Hospital 2 Leukapheresis 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡